Institute of Molecular and Cell Biology part of two recently awarded NRF OF-LCG projects led by National Cancer Centre Singapore

Institute of Molecular and Cell Biology shared a post on LinkedIn:

“Making an impact on patients’ lives by developing better ways to treat lymphoma and colorectal cancer in Singapore.

IMCB is proud to be part of two recently awarded NRF OF-LCG projects led by National Cancer Centre Singapore, SYMPHONY 2.0 and Colo-SCRIPT. The OF-LCG grant call supports patient-centric translational research with the goal of advancing human health and wellness and creating economic value.

These projects are made possible through the collaboration between National Cancer Center Singapore, National University of Singapore, National University Healthcare System, Nanyang Technological University (NTU), Singapore General Hospital (SGH) and our fellow A*STAR sister institutions, Bioinformatics Institute, A*STAR, Genome Institute of Singapore (GIS) and Singapore Immunology Network.

A huge congratulations to our Principal Investigators, Dr Valerie Yang (SYMPHONY 2.0), Prof Ashok Venkitaraman, Prof Vinay Tergaonkar and Prof Qi-Jing Li.”

Read further.
Source: Institute of Molecular and Cell Biology/LinkedIn